Biotech bubbles have been predicted several years ago but nobody seems to care about its existence. This is due to that fact many small biotech companies are actually in the scene monitoring commercial activities of the bigger biotech companies. They simply refused to go public because they didn’t want to be swallowed up the big and powerful companies.
Now, biotech stocks are picking up because young pharmaceutical companies are going public, daring the bigger ones. So, it is right time for die hard investors to going for biotech IPOs before the market become another rowdy scene which might eventually end the mad rush as it happens in the years past.